These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1938 related items for PubMed ID: 18665905
1. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
2. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
3. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
4. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L, Strong DM, Tegtmeier G, Stramer S. Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [Abstract] [Full Text] [Related]
5. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
6. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
7. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [Abstract] [Full Text] [Related]
8. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. Almeida RP, Cardoso DD. J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475 [Abstract] [Full Text] [Related]
9. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking]. Bal SH, Heper Y, Kumaş LT, Mistik R, Töre O. Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609 [Abstract] [Full Text] [Related]
10. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
11. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154 [Abstract] [Full Text] [Related]
12. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713 [Abstract] [Full Text] [Related]
13. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [Abstract] [Full Text] [Related]
14. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
15. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
18. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
19. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D, Chevaliez S, Pawlotsky JM. Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [Abstract] [Full Text] [Related]
20. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]